These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 35209140)
1. Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the Disease. Och A; Och M; Nowak R; Podgórska D; Podgórski R Molecules; 2022 Feb; 27(4):. PubMed ID: 35209140 [TBL] [Abstract][Full Text] [Related]
2. Traditional chinese medicine in treatment of metabolic syndrome. Yin J; Zhang H; Ye J Endocr Metab Immune Disord Drug Targets; 2008 Jun; 8(2):99-111. PubMed ID: 18537696 [TBL] [Abstract][Full Text] [Related]
3. Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies. Pirillo A; Catapano AL Atherosclerosis; 2015 Dec; 243(2):449-61. PubMed ID: 26520899 [TBL] [Abstract][Full Text] [Related]
4. Biological Activity of Berberine-A Summary Update. Och A; Podgórski R; Nowak R Toxins (Basel); 2020 Nov; 12(11):. PubMed ID: 33198257 [TBL] [Abstract][Full Text] [Related]
5. Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis. Xia X; Yan J; Shen Y; Tang K; Yin J; Zhang Y; Yang D; Liang H; Ye J; Weng J PLoS One; 2011 Feb; 6(2):e16556. PubMed ID: 21304897 [TBL] [Abstract][Full Text] [Related]
6. Effect and mechanism of berberine against polycystic ovary syndrome. Zhang SW; Zhou J; Gober HJ; Leung WT; Wang L Biomed Pharmacother; 2021 Jun; 138():111468. PubMed ID: 33740526 [TBL] [Abstract][Full Text] [Related]
7. Berberine in the Treatment of Diabetes Mellitus: A Review. Baska A; Leis K; Gałązka P Endocr Metab Immune Disord Drug Targets; 2021; 21(8):1379-1386. PubMed ID: 33092516 [TBL] [Abstract][Full Text] [Related]
8. Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review. Shinjyo N; Parkinson J; Bell J; Katsuno T; Bligh A J Integr Med; 2020 Mar; 18(2):125-151. PubMed ID: 32005442 [TBL] [Abstract][Full Text] [Related]
9. Berberine acutely inhibits the digestion of maltose in the intestine. Li ZQ; Zuo DY; Qie XD; Qi H; Zhao MQ; Wu YL J Ethnopharmacol; 2012 Jul; 142(2):474-80. PubMed ID: 22626925 [TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis. Zhao H; Xing C; Zhang J; He B Reprod Health; 2021 Aug; 18(1):171. PubMed ID: 34407851 [TBL] [Abstract][Full Text] [Related]
11. Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review. Xiong RG; Huang SY; Wu SX; Zhou DD; Yang ZJ; Saimaiti A; Zhao CN; Shang A; Zhang YJ; Gan RY; Li HB Molecules; 2022 Jul; 27(14):. PubMed ID: 35889396 [TBL] [Abstract][Full Text] [Related]
12. Preventive effect of geniposide on metabolic disease status in spontaneously obese type 2 diabetic mice and free fatty acid-treated HepG2 cells. Kojima K; Shimada T; Nagareda Y; Watanabe M; Ishizaki J; Sai Y; Miyamoto K; Aburada M Biol Pharm Bull; 2011; 34(10):1613-8. PubMed ID: 21963504 [TBL] [Abstract][Full Text] [Related]
13. [Progress of berberine for treatment of type 2 diabetes]. Deng XW; Xie N Zhongguo Zhong Yao Za Zhi; 2014 Apr; 39(8):1374-8. PubMed ID: 25039167 [TBL] [Abstract][Full Text] [Related]
14. The effect of Berberine on weight loss in order to prevent obesity: A systematic review. Ilyas Z; Perna S; Al-Thawadi S; Alalwan TA; Riva A; Petrangolini G; Gasparri C; Infantino V; Peroni G; Rondanelli M Biomed Pharmacother; 2020 Jul; 127():110137. PubMed ID: 32353823 [TBL] [Abstract][Full Text] [Related]
15. Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis. Zhang M; Lv X; Li J; Meng Z; Wang Q; Chang W; Li W; Chen L; Liu Y Mol Cell Endocrinol; 2012 Nov; 363(1-2):122-30. PubMed ID: 22922125 [TBL] [Abstract][Full Text] [Related]
16. Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota. Wang Y; Liu H; Zheng M; Yang Y; Ren H; Kong Y; Wang S; Wang J; Jiang Y; Yang J; Shan C Front Endocrinol (Lausanne); 2021; 12():609134. PubMed ID: 34025574 [TBL] [Abstract][Full Text] [Related]
17. Berberine and its derivatives: a patent review (2009 - 2012). Singh IP; Mahajan S Expert Opin Ther Pat; 2013 Feb; 23(2):215-31. PubMed ID: 23231038 [TBL] [Abstract][Full Text] [Related]
18. Effects of berberine in the gastrointestinal tract - a review of actions and therapeutic implications. Chen C; Yu Z; Li Y; Fichna J; Storr M Am J Chin Med; 2014; 42(5):1053-70. PubMed ID: 25183302 [TBL] [Abstract][Full Text] [Related]
19. Advance of studies on anti-atherosclerosis mechanism of berberine. Wu M; Wang J; Liu LT Chin J Integr Med; 2010 Apr; 16(2):188-92. PubMed ID: 20473748 [TBL] [Abstract][Full Text] [Related]
20. Antidiabetic properties of berberine: from cellular pharmacology to clinical effects. Cicero AF; Tartagni E Hosp Pract (1995); 2012 Apr; 40(2):56-63. PubMed ID: 22615079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]